Therapeutic Potential of EVs: Targeting Cardiovascular Diseases

Biomedicines. 2023 Jul 6;11(7):1907. doi: 10.3390/biomedicines11071907.

Abstract

Due to their different biological functions, extracellular vesicles (EVs) have great potential from a therapeutic point of view. They are released by all cell types, carrying and delivering different kinds of biologically functional cargo. Under pathological events, cells can increase their secretion of EVs and can release different amounts of cargo, thus making EVs great biomarkers as indicators of pathological progression. Moreover, EVs are also known to be able to transport and deliver cargo to different recipient cells, having an important role in cellular communication. Interestingly, EVs have recently been explored as biological alternatives for the delivery of therapeutics, being considered natural drug delivery carriers. Because cardiovascular disorders (CVDs) are the leading cause of death worldwide, in this review, we will discuss the up-to-date knowledge regarding the biophysical properties and biological components of EVs, focusing on myocardial infarction, diabetic cardiomyopathy, and sepsis-induced cardiomyopathy, three very different types of CVDs.

Keywords: EVs; cardiovascular diseases; diabetic cardiomyopathy; exosomes; extracellular vesicles; myocardial infarction; septic-induced cardiomyopathy.

Publication types

  • Review